[1] Cooper D N W. Galectinomics: Finding themes in complexity[J]. Biochim Biophys Acta, 2002, 1572(2): 209-231.
[2] Hughes R C. Secretion of the galectin family of mammalian carbohydratebinding proteins[J]. Biochim Biophys Acta, 1999, 1473(1): 172-185.
[3] Sciacchitano S, Lavra L, Morgante A, et al. Galectin3: One molecule for an alphabet of diseases, from a to z[J]. Int J of Mol Sci, 2018, 19(2): 379-438.
[4] Liu Y, Meng H, Xu S, et al. Galectins for diagnosis and prognostic assessment of human diseases: An overview of metaanalyses[J]. Med Sci Monit, 2020, 26: e923901
[5] Clementy N, Piver E, Bisson A, et al. Galectin3 in atrial fibrillation: Mechanisms and therapeutic implications[J]. Intl J Mol Sci, 2018, 19(4): 976-990.
[6] Dong R, Zhang M, Hu Q, et al. Galectin3 as a novel biomarker for disease diagnosis and a target for therapy: Review[J]. Int J Mol Med, 2018, 41(2): 599-614.
[7] Marchant V, Droguett A, Valderrama G, et al. Tubular overexpression of gremlin in transgenic mice aggravates renal damage in diabetic nephropathy[J]. Am J Physiol Renal Physiol, 2015, 309(6):559-568.
[8] Hara A, Niwa M, Noguchi K, et al. Galectin3 as a nextgeneration biomarker for detecting early stage of various diseases[J]. Biomolecules, 2020, 10(3): 389-408.
[9] Roff C F, Wang J L. Endogenous lectins from cultured cells. Isolation and characterization of carbohydratebinding proteins from 3T3 fibroblasts[J]. J Biol Chem, 1983, 258(17): 10657-10663.
[10] Chen S C, Kuo P L. The role of galectin3 in the kidneys[J]. Int J Mol Sci, 2016, 17(4): 565-575.